Insulet targets 2028 launch of fully closed-loop insulin delivery system for type 2 diabetes

By Public Technologies
  • Insulet targets a 2028 launch of fully closed-loop automated insulin delivery for type 2 diabetes, with a 2027 regulatory filing.
  • The addressable market exceeds $30 billion; the automated insulin delivery market could reach about $9 billion by 2028.
  • U.S. type 2 diabetes market penetration is targeted at 10-15% by 2028, compared with about 5% today.
  • U.S. type 1 diabetes market penetration is projected to reach 50-55% by 2028, versus about 40% today.
  • Revenue reached $2.7 billion in 2025, with an adjusted operating margin of 17.6%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insulet Corporation published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.